PARTNER THERAPEUTICS LIMITED

Partner Therapeutics (PTx) is an integrated biotechnology company dedicated to advancing late‑stage therapeutics that enhance health outcomes for patients battling cancer and other serious illnesses. By combining cutting‑edge research with a clear commercial focus, PTx develops and brings to market innovative treatments that address unmet medical needs, while also pioneering host‑directed therapies aimed at global health security threats.

The company’s purpose centres on delivering high‑quality products and supporting medical teams, ensuring that patients and their families receive the best possible care. Through its specialised expertise in both oncology and infectious‑disease therapeutics, Partner Therapeutics works closely with clinicians and research partners to translate scientific breakthroughs into real‑world solutions that improve survival and quality of life.